Raynaud's phenomenon epidemiology and demographics

Raynaud's phenomenon Microchapters
Home
Patient Information
Overview
Pathophysiology
Causes
Differentiating Raynaud's phenomenon from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Raynaud's phenomenon epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Raynaud's phenomenon epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Raynaud's phenomenon epidemiology and demographics
CDC onRaynaud's phenomenon epidemiology and demographics
Raynaud's phenomenon epidemiology and demographics in the news
Blogs on Raynaud's phenomenon epidemiology and demographics
Directions to Hospitals Treating Raynaud's phenomenon
Risk calculators and risk factors for Raynaud's phenomenon epidemiology and demographics

Editors-In-Chief: Asghar Fakhri, M.D., Duane S. Pinto, M.D. and C. Michael Gibson, M.S., M.D.

Epidemiology

There is a familial component to primary Raynaud's, and presentation is typically before 30. Smoking worsens frequency and intensity of attacks, and there is a hormonal component. Sufferers are more likely to have migraine and angina than controls.

Incidence

The phenomenon is more common in women than men, with the Framingham Study finding that 5.8% of men and 9.6% of women suffered from it.

References

Template:WikiDoc Sources